Alerts will be sent to your verified email
Verify Email
MEDIORG
|
Medicamen Organics
|
Parmax Pharma
|
JFL Life Sciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
13.81 % | 24.13 % | 12.26 % |
|
5yr average Equity Multiplier
|
2.71 | 29.23 | 2.68 |
|
5yr Average Asset Turnover Ratio
|
0.66 | 1.05 | 0.93 |
|
5yr Avg Net Profit Margin
|
8.45 % | -11.29 % | 5.75 % |
|
Price to Book
|
0.0 | 0.0 | 0.65 |
|
P/E
|
0.0 | 0.0 | 4.67 |
|
5yr Avg Cash Conversion Cycle
|
-17.75 Days | -92.25 Days | 138.58 Days |
|
Inventory Days
|
81.12 Days | 69.37 Days | 96.42 Days |
|
Days Receivable
|
203.36 Days | 20.01 Days | 135.23 Days |
|
Days Payable
|
289.0 Days | 296.94 Days | 103.44 Days |
|
5yr Average Interest Coverage Ratio
|
7.35 | -0.77 | 4.03 |
|
5yr Avg ROCE
|
22.44 % | -14.3 % | 17.72 % |
|
5yr Avg Operating Profit Margin
|
14.84 % | 2.43 % | 10.31 % |
|
5 yr average Debt to Equity
|
0.85 | 10.96 | 0.9 |
|
5yr CAGR Net Profit
|
33.09 % | n/a | 50.43 % |
|
5yr Average Return on Assets
|
5.55 % | -9.05 % | 5.01 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
59.73 % | 30.8 % | 67.47 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.04 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Medicamen Organics
|
Parmax Pharma
|
JFL Life Sciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|